English中文

Offstream
news



Changes

  1. AstraZeneca-Oxford developers say that their vaccine candidate works against the UK variant of SARS-CoV-2.
  2. AstraZeneca-Oxford developers say that their vaccine candidate is effective against the UK variant of SARS-CoV-2.

Related